Advertisement
BELLUS Health Inc. (BLU)
BELLUS Health Statistics
Share Statistics
BELLUS Health has 126.81M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 126.81M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 92.13M |
| Failed to Deliver (FTD) Shares | 166K |
| FTD / Avg. Volume | 3.08% |
Short Selling Information
The latest short interest is 6.65M, so 5.24% of the outstanding shares have been sold short.
| Short Interest | 6.65M |
| Short % of Shares Out | 5.24% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.58 |
Valuation Ratios
The PE ratio is -12.46 and the forward PE ratio is null. BELLUS Health's PEG ratio is 0.47.
| PE Ratio | -12.46 |
| Forward PE | n/a |
| PS Ratio | 59265.57 |
| Forward PS | n/a |
| PB Ratio | 2.43 |
| P/FCF Ratio | -9.68 |
| PEG Ratio | 0.47 |
Enterprise Valuation
BELLUS Health has an Enterprise Value (EV) of 862.28M.
| EV / Sales | 53892.63 |
| EV / EBITDA | -11.85 |
| EV / EBIT | -11.18 |
| EV / FCF | -8.8 |
Financial Position
The company has a current ratio of 22.42, with a Debt / Equity ratio of 0.
| Current Ratio | 22.42 |
| Quick Ratio | 22.42 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.01 |
| Interest Coverage | -998.5 |
Financial Efficiency
Return on Equity is -19.46% and Return on Invested Capital is -19.87%.
| Return on Equity | -19.46% |
| Return on Assets | -18.66% |
| Return on Invested Capital | -19.87% |
| Revenue Per Employee | $216.22 |
| Profits Per Employee | $-1.03M |
| Employee Count | 74 |
| Asset Turnover | 0 |
| Inventory Turnover | 3.51B |
Taxes
| Income Tax | 60K |
| Effective Tax Rate | -0.08% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is -0.28, so BELLUS Health's price volatility has been lower than the market average.
| Beta | -0.28 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 14.55 |
| 200-Day Moving Average | 10.13 |
| Relative Strength Index (RSI) | 78.88 |
| Average Volume (20 Days) | 5.38M |
Income Statement
In the last 12 months, BELLUS Health had revenue of 16K and earned -76.08M in profits. Earnings per share was -0.66.
| Revenue | 16K |
| Gross Profit | -3.51B |
| Operating Income | -77.88M |
| Net Income | -76.08M |
| EBITDA | -72.76M |
| EBIT | -75.94M |
| Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has 87.25M in cash and 1.28M in debt, giving a net cash position of 85.97M.
| Cash & Cash Equivalents | 87.25M |
| Total Debt | 1.28M |
| Net Cash | 85.97M |
| Retained Earnings | -641.84M |
| Total Assets | 3.09B |
| Working Capital | 890.08M |
Cash Flow
In the last 12 months, operating cash flow was -77.1M and capital expenditures -20.89M, giving a free cash flow of -97.98M.
| Operating Cash Flow | -77.1M |
| Capital Expenditures | -20.89M |
| Free Cash Flow | -97.98M |
| FCF Per Share | -0.85 |
Margins
Gross margin is -21967104.08%, with operating and profit margins of -486768.75% and -475500%.
| Gross Margin | -21967104.08% |
| Operating Margin | -486768.75% |
| Pretax Margin | -475125% |
| Profit Margin | -475500% |
| EBITDA Margin | -454768.75% |
| EBIT Margin | -486768.75% |
| FCF Margin | -612387.7% |
Dividends & Yields
BLU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.02% |
| FCF Yield | -10.33% |
Analyst Forecast
Currently there are no analyst rating for BLU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 19, 2019. It was a backward split with a ratio of 5:18.
| Last Split Date | Aug 19, 2019 |
| Split Type | backward |
| Split Ratio | 5:18 |
Scores
| Altman Z-Score | 1.12 |
| Piotroski F-Score | 3 |